MicroRNA‑155 targets myosin light chain kinase to inhibit the migration of human bone marrow‑derived mesenchymal stem cells

Wang,Xingbing; Ye,Xu; Ji,Jingjuan; Wang,Jian; Xu,Bo; Zhang,Qian; Ming,Jing; Liu,Xin

doi:10.3892/ijmm.2018.3718

MicroRNA‑155 targets myosin light chain kinase to inhibit the migration of human bone marrow‑derived mesenchymal stem cells

Authors:
- Xingbing Wang
- Xu Ye
- Jingjuan Ji
- Jian Wang
- Bo Xu
- Qian Zhang
- Jing Ming
- Xin Liu
View Affiliations

Affiliations: Department of Hematology, The First Affiliated Hospital, University of Science and Technology of China, Hefei, Anhui 230001, P.R. China, Reproductive Medicine Center, The First Affiliated Hospital, University of Science and Technology of China, Hefei, Anhui 230001, P.R. China
Published online on: June 5, 2018 https://doi.org/10.3892/ijmm.2018.3718
Pages: 1585-1592

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Toll‑like receptors (TLRs) are expressed in human bone marrow‑derived mesenchymal stromal cells (BM‑MSCs). The activation of TLRs is important in the proliferation, differentiation, migration and hematopoiesis‑supporting functions of BM‑MSCs. MicroRNAs (miRNAs) are involved in various biological functions by mediating mRNA degradation or inhibiting the translation of target genes. Our previous study confirmed that TLRs regulate the migration ability of BM‑MSCs. It was also identified that multiple miRNAs were regulated by TLRs. In view of this, it was hypothesized that TLR‑regulated miRNAs may be important in regulating the migration of BM‑MSCs. The migration ability of BM‑MSCs was evaluated following transfection of the cells with the mimics or antagonists of miRNA (miR)‑27b, miR‑146a, miR‑155 and miR‑154. miR‑155 significantly inhibited cell migration. Myosin light chain kinase (MYLK) was identified as the direct target of miR‑155 in BM‑MSCs, which was further investigated using the luciferase reporter assay. However, miR‑155 did not affect the expression of upstream proteins of the RhoA pathway controlling the activity of MYLK, suggesting that miR‑155 directly suppressed the expression of MYLK without affecting the RhoA pathway. These results may facilitate the development and clinical use of BM‑MSCs in terms of their migration.

View Figures

View References

1	Yates LA, Norbury CJ and Gilbert RJ: The long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
2	Bartel DP: MicroRNAs: Target recognition and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
3	Moreno-Moya JM, Vilella F and Simón C: MicroRNA: Key gene expression regulators. Fertil Steril. 101:1516–1523. 2014. View Article : Google Scholar
4	Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
5	Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, et al: Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 418:41–49. 2002. View Article : Google Scholar : PubMed/NCBI
6	Charbord P: Bone marrow mesenchymal stem cells: Historical overview and concepts. Hum Gene Ther. 21:1045–1056. 2010. View Article : Google Scholar : PubMed/NCBI
7	Oreffo RO, Cooper C, Mason C and Clements M: Mesenchymal stem cells: Lineage, plasticity, and skeletal therapeutic potential. Stem Cell Rev. 1:169–178. 2005. View Article : Google Scholar
8	Spaeth E, Klopp A, Dembinski J, Andreeff M and Marini F: Inflammation and tumor microenvironments: Defining the migratory itinerary of mesenchymal stem cells. Gene Ther. 15:730–738. 2008. View Article : Google Scholar : PubMed/NCBI
9	Chamberlain G, Fox J, Ashton B and Middleton J: Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 25:2739–2749. 2007. View Article : Google Scholar : PubMed/NCBI
10	Fox JM, Chamberlain G, Ashton BA and Middleton J: Recent advances into the understanding of mesenchymal stem cell trafficking. Br J Haematol. 137:491–502. 2007. View Article : Google Scholar : PubMed/NCBI
11	Warnke PH, Wiltfang J, Springer I, Acil Y, Bolte H, Kosmahl M, Russo PA, Sherry E, Lützen U, Wolfart S and Terheyden H: Man as living bioreactor: Fate of an exogenously prepared customized tissue-engineered mandible. Biomaterials. 27:3163–3167. 2006. View Article : Google Scholar : PubMed/NCBI
12	Ren C, Kumar S, Chanda D, Kallman L, Chen J, Mountz JD and Ponnazhagan S: Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model. Gene Ther. 15:1446–1453. 2008. View Article : Google Scholar : PubMed/NCBI
13	Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ and Andreeff M: Bone marrow derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res. 62:3603–3608. 2002.PubMed/NCBI
14	Pontikoglou C, Deschaseaux F, Sensebé L and Papadaki HA: Bone marrow mesenchymal stem cells: Biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation. Stem Cell Rev. 7:569–589. 2011. View Article : Google Scholar : PubMed/NCBI
15	Kollmann TR, Levy O, Montgomery RR and Goriely S: Innate immune function by Toll-like receptors: Distinct responses in newborns and the elderly. Immunity. 37:771–783. 2012. View Article : Google Scholar : PubMed/NCBI
16	Shirjang S, Mansoori B, Solali S, Hagh MF and Shamsasenjan K: Toll-like receptors as a key regulator of mesenchymal stem cell function: An up-to-date review. Cell Immunol. 315:1–10. 2017. View Article : Google Scholar : PubMed/NCBI
17	Wang X, Cheng Q, Li L, Wang J, Xia L, Xu X and Sun Z: Toll-like receptors 2 and 4 mediate the capacity of mesenchymal stromal cells to support the proliferation and differentiation of CD34⁺ cells. Exp Cell Res. 318:196–206. 2012. View Article : Google Scholar
18	Lei J, Wang Z, Hui D, Yu W, Zhou D, Xia W, Chen C, Zhang Q, Wang Z, Zhang Q and Xiang AP: Ligation of TLR2 and TLR4 on murine bone marrow-derived mesenchymal stem cells triggers differential effects on their immunosuppressive activity. Cell Immunol. 271:147–156. 2011. View Article : Google Scholar : PubMed/NCBI
19	Yang ZH, Wang XB, Wang J, Li LL and Zhu YX: Influence of TLR2 and TLR4 agonists on migration of human bone marrow mesenchymal stem cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 22:183–186. 2014.In Chinese. PubMed/NCBI
20	Benakanakere MR, Li Q, Eskan MA, Singh AV, Zhao J, Galicia JC, Stathopoulou P, Knudsen TB and Kinane DF: Modulation of TLR2 protein expression by miR-105 in human oral keratinocytes. J Biol Chem. 284:23107–23115. 2009. View Article : Google Scholar : PubMed/NCBI
21	Quinn EM, Wang JH, O'Callaghan G and Redmond HP: MicroRNA-146a is upregulated by and negatively regulates TLR2 signaling. PLoS One. 8:e622322013. View Article : Google Scholar : PubMed/NCBI
22	O'Hara SP, Splinter PL, Gajdos GB, Trussoni CE, Fernandez-Zapico ME, Chen XM and LaRusso NF: NFkappaB p50-CCAAT/enhancer-binding protein beta (C/EBPbeta)-mediated transcriptional repression of microRNA let-7i following microbial infection. J Biol Chem. 285:216–225. 2010. View Article : Google Scholar
23	Yang K, He YS, Wang XQ, Lu L, Chen QJ, Liu J, Sun Z and Shen WF: MiR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4. FEBS Lett. 585:854–860. 2011. View Article : Google Scholar : PubMed/NCBI
24	Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA and Croce CM: Modulation of miR-155 and miR-125b levels following lipo-polysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol. 179:5082–5089. 2007. View Article : Google Scholar : PubMed/NCBI
25	Curtale G, Mirolo M, Renzi TA, Rossato M, Bazzoni F and Locati M: Negative regulation of Toll-like receptor 4 signaling by IL-10-dependent microRNA-146b. Proc Natl Acad Sci USA. 110:11499–11504. 2013. View Article : Google Scholar : PubMed/NCBI
26	Ceppi M, Pereira PM, Dunand-Sauthier I, Barras E, Reith W, Santos MA and Pierre P: MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci USA. 106:2735–2740. 2009. View Article : Google Scholar : PubMed/NCBI
27	Wang X, Zhu Y, Xu B, Wang J and Liu X: Identification of TLR2 and TLR4-induced microRNAs in human mesenchymal stem cells and their possible roles in regulating TLR signals. Mol Med Rep. 13:4969–4980. 2016. View Article : Google Scholar : PubMed/NCBI
28	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−delta delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
29	Skårn M, Namløs HM, Noordhuis P, Wang MY, Meza-Zepeda LA and Myklebost O: Adipocyte differentiation of human bone marrow-derived stromal cells is modulated by microRNA-155, microRNA-221, and microRNA-222. Stem Cells Dev. 21:873–883. 2012. View Article : Google Scholar
30	Xu C, Ren G, Cao G, Chen Q, Shou P, Zheng C, Du L, Han X, Jiang M, Yang Q, et al: miR-155 regulates immune modulatory properties of mesenchymal stem cells by targeting TAK1-binding protein 2. J Biol Chem. 288:11074–11079. 2013. View Article : Google Scholar : PubMed/NCBI
31	Lazar V and Garcia JG: A single human myosin light chain kinase gene (MLCK; MYLK). Genomics. 57:256–267. 1999. View Article : Google Scholar : PubMed/NCBI
32	Kamm KE and Stull JT: Dedicated myosin light chain kinases with diverse cellular functions. J Biol Chem. 276:4527–4530. 2001. View Article : Google Scholar
33	Weber M, Kim S, Patterson N, Rooney K and Searles CD: MiRNA-155 targets myosin light chain kinase and modulates actin cytoskeleton organization in endothelial cells. Am J Physiol Heart Circ Physiol. 306:H1192–H1203. 2014. View Article : Google Scholar : PubMed/NCBI
34	Miao H, Crabb AW, Hernandez MR and Lukas TJ: Modulation of factors affecting optic nerve head astrocyte migration. Invest Ophthalmol Vis Sci. 51:4096–4103. 2010. View Article : Google Scholar : PubMed/NCBI
35	Hsieh JY, Huang TS, Cheng SM, Lin WS, Tsai TN, Lee OK and Wang HW: miR-146a-5p circuitry uncouples cell proliferation and migration, but not differentiation, in human mesenchymal stem cells. Nucleic Acids Res. 41:9753–9763. 2013. View Article : Google Scholar : PubMed/NCBI
36	Lü MH, Li CZ, Hu CJ, Fan YH, Wang SM, Wu YY, Liang GP and Yang SM: microRNA-27b suppresses mouse MSC migration to the liver by targeting SDF-1α in vitro. Biochem Biophys Res Commun. 421:389–395. 2012. View Article : Google Scholar